Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z6SS
|
|||
| Former ID |
DNC009107
|
|||
| Drug Name |
1-Adamantan-1-yl-3-phenyl-urea
|
|||
| Synonyms |
1-Adamantan-1-yl-3-phenyl-urea; CHEMBL516415; AC1MJEST; BAS 00102691; AC1Q5LN2; Oprea1_605405; Oprea1_553434; SCHEMBL1420838; IFLab1_001789; 1-(1-adamantyl)-3-phenylurea; 1-adamantan-1-yl-3-phenylurea; N-(1-adamantyl)-N'-phenylurea; 1-(1-adamantyl)-3-phenyl-urea; BOKJLWGPHOTBQZ-UHFFFAOYSA-N; MolPort-000-434-175; HMS1417B07; 3-(adamantan-1-yl)-1-phenylurea; ZINC6645734; N-adamantanyl(phenylamino)carboxamide; STL263876; BDBM50267067; AKOS003625202; AKOS001215839; MCULE-9094796377; UPCMLD0ENAT5533559:001; ST50049182; SR-01000363562
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H22N2O
|
|||
| Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=CC=C4
|
|||
| InChI |
1S/C17H22N2O/c20-16(18-15-4-2-1-3-5-15)19-17-9-12-6-13(10-17)8-14(7-12)11-17/h1-5,12-14H,6-11H2,(H2,18,19,20)
|
|||
| InChIKey |
BOKJLWGPHOTBQZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Peroxisome | ||||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Metapathway biotransformation | |||
| Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1784-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.